Eye Diseases: Symptoms & Causes of 19 Common Eye Problems - WebMD
Nov 6, 2024 · Get information on common eye and vision problems, such as conjunctivitis, retinal detachment, dry eyes, cataracts, and glaucoma.
Eye Disease: Types, Symptoms, Causes and Treatment | U.S. News
Feb 26, 2025 · Learn the types, symptoms, causes and treatments for the most common eye diseases and how you can protect your vision long-term.
Eye Problems - Symptoms A to Z - All About Vision
Jan 17, 2019 · Is something wrong with your eyes? Find symptoms in the list below, then look to the right for associated eye problems and diseases. To learn more, click on the eye problem or …
Eye problems: Common conditions and how to prevent vision loss
Oct 27, 2021 · What are some common eye problems? Read on to learn more about common eye conditions and tips to help prevent vision loss.
Eye disease - Wikipedia
Eye disease This is a partial list of human eye diseases and disorders. The World Health Organization (WHO) publishes a classification of known diseases and injuries, the International …
Most Common Eye Problems - Signs, Symptoms & Treatment
Jun 4, 2020 · Know about the signs and symptoms of most common eye problems including Macular Degeneration, Cataracts, Glaucoma, Diabetic Retinopathy, Conjunctivitis etc.
Medical Treatments for Vision Problems - massivebio.com
3 days ago · These solutions are vital for managing progressive eye diseases and rehabilitating visual function. They provide accessible and less invasive ways for individuals to experience …
Researchers find genetic basis for important risk factor in blinding ...
2 days ago · Researchers find genetic basis for important risk factor in blinding eye disease International collaboration provides clues about important subtype of age-related macular …
New $21m research collaboration to develop treatments for eye diseases
Dec 3, 2025 · The three-year initiative aims to develop two new treatments for glaucoma and myopia. Read more at straitstimes.com. Read more at straitstimes.com.
Théa pens $280M deal for Iolyx's phase 3-ready eye disease drug
6 days ago · Laboratoires Théa has penned a deal potentially worth up to $280 million to get its hands on Iolyx Therapeutics’ phase 3-ready eye disease drug.